News | Coronavirus (COVID-19) | June 18, 2020

AI-powered Diagnostic Solution From QuEST Global to Accelerate COVID-19 Screening

QuEST Global, a global product engineering and lifecycle services company, announced that it has developed a robust artificial intelligence (AI)-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms.

Getty Images

June 18, 2020 — QuEST Global, a global product engineering and lifecycle services company, announced that it has developed a robust artificial intelligence (AI)-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms. Using advanced deep learning models, the AI-powered diagnostic solution can sort and identify chest X-rays of patients with COVID-19. With an accuracy of more than 95%, the solution can be deployed on the cloud as a service, making it easily accessible on edge for healthcare professionals and end-users. The solution is backed by Microsoft Azure Machine Learning, which helps accelerate the development and deployment on machine learning models in a highly secure and trusted fashion.

The Medical Devices engineering team at QuEST developed this technology demonstrator using chest X-rays of healthy individuals, patients with symptoms of pneumonia and COVID-19. These X-rays were used to train and build a deep neural network model that could discriminate the radiological patterns of pneumonia related to COVID-19 and highlight the suspicious ones, thus leading to a faster screening of the disease.

Elaborating further on QuEST's AI solution, Krish Kupathil, Global Head, Hi-Tech and Digital, QuEST Global, said, "As the pandemic continues to rage, our focus has been to deliver a solution that can support the healthcare professionals effectively. Since the fight against COVID-19 is all about faster screening and immediate isolation of maximum number of people, we aim to accelerate the screening time as much as possible. The AI-based solution will make radiography examinations much faster by leveraging modern image diagnostic systems. As we continue to add more features, we aim to reduce the screening time to less than a minute."

Michael Kuptz, General Manager – Americas IoT & Mixed Reality Sales, Microsoft, said, "In these unprecedented times, saving human lives is the ultimate goal, and technology can help. Microsoft's collaborations with product engineering leaders like QuEST can go a long way to driving a more positive outcome. For example, QuEST's AI-driven diagnostic solution, built on Microsoft Azure, empowers healthcare personnel in the fight against COVID-19 by reducing screening time, thereby enabling more testing capacity."

Over the years, QuEST has been working as a trusted thinking partner with the world's most recognized companies in the medical devices industry. The company is committed to enabling its customers Create The Frontier by enhancing healthcare experience to improve the lives of millions of people around the world. With its expertise in new-age technologies like deep learning, AI, IoT and machine learning, the company has been developing comprehensive engineering solutions by using Azure IoT and Azure AI solutions. These solutions have been helping OEMs, and tier-one suppliers seamlessly take a giant leap in their digital transformation journey and make products safer and more reliable.

For more information: www.quest-global.com

Related Content

Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed an agreement with Invitae Corporation, a leader in medical genetics, to bring Invitae's genetic testing services to Volpara's customers in the United States. 
News | Breast Imaging | July 29, 2021
July 29, 2021 — Volpara Health, a global health technology software leader providing an...
Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery.

Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One.

Feature | Ultrasound Imaging | July 28, 2021
Outside of medicine, computer-generated virtual twins of real machines like cars or airplanes have been used in engin
If you plan to attend HIMSS21 Aug. 9-13 in Las Vegas, be sure to note that due to health and safety updates, masks will now be required for attendees and exhibitors.

Getty Images

News | HIMSS | July 28, 2021
July 28, 2021 —If you plan to attend HIMSS21 Aug.
Researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London have automated brain MRI image labeling, needed to teach machine learning image recognition models, by deriving important labels from radiology reports and accurately assigning them to the corresponding MRI examinations

Getty Images

News | Magnetic Resonance Imaging (MRI) | July 28, 2021
July 28, 2021 — Researchers from the School of Biomedical Engineering & Imaging Sciences at...
A new Harvey L. Neiman Health Policy Institute study found that patients paid 12% of the costs of secondary imaging interpretation out-of-pocket. Such secondary interpretations are increasingly performed for complex patients, but patients’ liabilities and paid out-of-pocket costs were not previously known.

Getty Images

News | Radiology Imaging | July 28, 2021
July 28, 2021 — A new Harvey L.